Bicara Therapeutics Expands Management Team with the Appointment of David Raben, M.D., as Chief Medical Officer
Company
Bicara Therapeutics
BostonBiotechnologyHealth CareTherapeuticsDescription
Bicara Therapeutics, a clinical-stage biotechnology company developing dual-action biologics to elicit a potent and durable immune response, today announced the appointment of David Raben, M.D., as chief medical officer. Dr. Raben joins Bicara with more than 25 years of biopharma and academic translational oncology experience, having most recently served as vice president of global product development and product general manager, oncology, at Amgen.
Quick answer
Bicara Therapeutics Expands Management Team with the Appointment of David Raben, M.D., as Chief Medical Officer (July 24, 2023). Bicara Therapeutics is based in Boston, Massachusetts, United States.
- What did Bicara Therapeutics announce on July 24, 2023?
- Bicara Therapeutics, a clinical-stage biotechnology company developing dual-action biologics to elicit a potent and durable immune response, today announced the appointment of David Raben, M.D., as chief medical officer. Dr. Raben joins Bicara with more than 25 years of biopharma and academic translational oncology experience, having most recently served as vice president of global product development and product...
- What does Bicara Therapeutics do?
- Bicara Therapeutics is a clinical-stage biotechnology company developing first-in-class biologics engineered to combine the precision of well validated, tumor-targeting antibodies with the power of tumor...
- Where is Bicara Therapeutics based?
- Bicara Therapeutics is based in Boston, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Pheon Therapeutics (July 25, 2023), Acadia Pharmaceuticals (July 25, 2023), Pfizer (July 27, 2023) and Neumora (July 18, 2023) also announced leadership changes within 45 days of Bicara Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Pheon Therapeutics Appoints Industry Veteran Cyrus Mozayeni, MD as Chief Executive Officer (July 25, 2023)
- Acadia Pharmaceuticals Appoints Kevin Oliver Chief Business Officer (July 25, 2023)
- Pfizer (PFE) Appoints Chris Boshoff as Chief Oncology Research and Development Officer (July 27, 2023)
- Neumora Therapeutics Names Henry Gosebruch as President and Chief Executive Officer (July 18, 2023)
- Ambrx Appoints Renu Vaish, M.Sc., as Chief Regulatory Officer to Lead Regulatory Affairs (August 1, 2023)
- Karuna Therapeutics Announces Leadership Appointments (August 3, 2023)
Who to call at Bicara Therapeutics, and when
A new leader at Bicara Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Bicara Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Bicara Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Bicara Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Bicara Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Bicara Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.